Business Description
Sprint Bioscience AB
ISIN : SE0006343745
Compare
Compare
Traded in other countries / regions
SPRINT.Sweden5JA1.Germany IPO Date
2014-11-07Description
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.29 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -5.83 | |||||
| Beneish M-Score | -1.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.2 | |||||
| 3-Year EBITDA Growth Rate | 75.6 | |||||
| 3-Year EPS without NRI Growth Rate | 83.7 | |||||
| 3-Year Book Growth Rate | 4.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.19 | |||||
| 9-Day RSI | 62.93 | |||||
| 14-Day RSI | 58.18 | |||||
| 6-1 Month Momentum % | 67.08 | |||||
| 12-1 Month Momentum % | 7.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.28 | |||||
| Quick Ratio | 1.28 | |||||
| Cash Ratio | 0.97 | |||||
| Days Sales Outstanding | 4.86 | |||||
| Days Payable | 85.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -38.7 | |||||
| Shareholder Yield % | 0.2 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.54 | |||||
| Operating Margin % | -35.82 | |||||
| Net Margin % | -31.72 | |||||
| FCF Margin % | -34.31 | |||||
| ROE % | -81.34 | |||||
| ROA % | -35.03 | |||||
| ROIC % | -73.53 | |||||
| ROC (Joel Greenblatt) % | -516.11 | |||||
| ROCE % | -87.96 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.13 | |||||
| PB Ratio | 9.52 | |||||
| Price-to-Tangible-Book | 9.68 | |||||
| EV-to-EBIT | -4.68 | |||||
| EV-to-EBITDA | -4.92 | |||||
| EV-to-Revenue | 1.61 | |||||
| EV-to-FCF | -3.92 | |||||
| Price-to-Net-Current-Asset-Value | 14.15 | |||||
| Earnings Yield (Greenblatt) % | -21.34 | |||||
| FCF Yield % | -16.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sprint Bioscience AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 60.252 | ||
| EPS (TTM) (kr) | -0.27 | ||
| Beta | 0 | ||
| Volatility % | 69.66 | ||
| 14-Day RSI | 58.18 | ||
| 14-Day ATR (kr) | 0.213639 | ||
| 20-Day SMA (kr) | 1.7285 | ||
| 12-1 Month Momentum % | 7.14 | ||
| 52-Week Range (kr) | 0.756 - 2.25 | ||
| Shares Outstanding (Mil) | 69.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sprint Bioscience AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sprint Bioscience AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sprint Bioscience AB Frequently Asked Questions
What is Sprint Bioscience AB(OSTO:SPRINT)'s stock price today?
The current price of OSTO:SPRINT is kr1.84. The 52 week high of OSTO:SPRINT is kr2.25 and 52 week low is kr0.76.
When is next earnings date of Sprint Bioscience AB(OSTO:SPRINT)?
The next earnings date of Sprint Bioscience AB(OSTO:SPRINT) is 2025-02-12.
Does Sprint Bioscience AB(OSTO:SPRINT) pay dividends? If so, how much?
Sprint Bioscience AB(OSTO:SPRINT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers